Skip to content
OpenCapital
Get started

HealthEquity HQY Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net

Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net at other companies

MSCI logo
MSCIMSCI
$51.4M+78.5%
General Dynamics logo
General DynamicsGD
$58M-15.9%
Carrier Global logo
Carrier GlobalCARR
$76M-11.6%
Keysight Technologies logo
Keysight TechnologiesKEYS
$6M—
L3Harris Technologies logo
L3Harris TechnologiesLHX
$43M—
Duke Energy logo
Duke EnergyDUK
$1B0.0%

Other financials

Income statement

See full
Revenue$354.6M+7.2%
Gross profit$256.3M+14.3%
Operating income$103.0M+23.9%
Net income$69.4M+28.8%
EPS (diluted)$0.82+34.4%

Balance sheet

See full
Cash & equivalents$265.4M-7.8%
Total debt$984.7M-11.0%
Total equity$2.0B-3.6%
Total assets$3.3B-3.2%

Cash flow

See full
Operating cash flow$97.5M+50.6%
CapEx$362.0K+321%
Free cash flow$97.2M+50.3%

Valuation

See full
Market cap$7.12B-6.7%
Enterprise value$7.84B-7.2%
P/E30.9×-31.8×
P/S5.3×-0.8×

Profitability

See full
Gross margin70.7%+5.2pp
Operating margin25.6%+9.2pp
Net margin17.3%+7.5pp
FCF margin36.5%+9.3pp

Returns & leverage

See full
Return on equity11.1%+5.3pp
Debt / equity0.5×0.0×
Current ratio3.4×-0.6×

Where this comes from

Reported directly by HealthEquity in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet.

The official record: HealthEquity’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about HealthEquity's debt instrument, unamortized discount (premium) and debt issuance costs, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HealthEquity's debt instrument, unamortized discount (premium) and debt issuance costs, net?
HealthEquity (HQY) reported debt instrument, unamortized discount (premium) and debt issuance costs, net of $4.22M in Q1 2026.
How has HealthEquity's debt instrument, unamortized discount (premium) and debt issuance costs, net changed year-over-year?
HealthEquity's debt instrument, unamortized discount (premium) and debt issuance costs, net decreased by 20.5% year-over-year, from $5.31M to $4.22M.
What is the long-term trend for HealthEquity's debt instrument, unamortized discount (premium) and debt issuance costs, net?
Over 5 years (2021 to 2026), HealthEquity's debt instrument, unamortized discount (premium) and debt issuance costs, net has grown at a -22.8% compound annual growth rate (CAGR), from $16.41M to $4.5M.